| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 10/20/2005 | US20050233955 Stimulation of nerve cell regeneration |
| 10/20/2005 | US20050233951 Novel two gonadotropin releasing hormones and a method to isolate the same |
| 10/20/2005 | US20050233941 Pin coated assay |
| 10/20/2005 | US20050233475 Joining compound to magnetic beads; quantitative analysis |
| 10/20/2005 | US20050233474 Surface-enhanced Raman spectroscopy for biosensor systems and methods for determining the presence of biomolecules |
| 10/20/2005 | US20050233473 Methods and reagents for surface functionalization |
| 10/20/2005 | US20050233472 Spotting high density plate using a banded format |
| 10/20/2005 | US20050233471 Method of assaying the antioxidant activity of pure compounds, extracts and biological fluids |
| 10/20/2005 | US20050233469 Activity-based probes for protein tyrosine phosphatases |
| 10/20/2005 | US20050233467 Visible wavelength fluorescent calcium indicators that are (i) leakage resistant and (ii) operate near membranes |
| 10/20/2005 | US20050233466 An agitator vane is mounted at a pivot point and sweeps about the pivot point and through the test sample when the sample is not coagulated; coagulation test time from the commencement of sweeping until detection of reduction (including cessation) of the sweeping movement is dermined |
| 10/20/2005 | US20050233463 Method and device for the detection of SF6 decomposition products |
| 10/20/2005 | US20050233462 cyanine dye derivatives used as fluorescent labels for multiplex analysis |
| 10/20/2005 | US20050233461 High-throughput methods and systems for screening of compounds to treat/prevent kidney disorders |
| 10/20/2005 | US20050233460 Determining coagulation time; thrombin, prothrombin, partial thromboplastin, or activated clotting times, using a test cartridge with agitator vane leaflets that can be swept through the test sample in the absence of coagulation; resistance to agitator movement due to coagulation is detected |
| 10/20/2005 | US20050233446 Defined media for stem cell culture |
| 10/20/2005 | US20050233439 Optical method and system to determine distribution of lipid particles in a sample |
| 10/20/2005 | US20050233438 Flat macroporous support material with pores extending the length of surface; silicon dioxide walls; DNA, proteins, oligonucleotide probes captured by covalent binding |
| 10/20/2005 | US20050233417 Growth hormone variations in humans and their uses |
| 10/20/2005 | US20050233410 Detecting cancerous and precancerous cells; obtain tissue sample, incubate wih tetrakis dyes, rince and remove unbound dye, detect fluorescence, fuorescence indicates cancerous or precancerous cells |
| 10/20/2005 | US20050233406 Methods for high resolution identification of solvent accessible amide hydrogens in polypeptides and for characterization of polypeptide structure |
| 10/20/2005 | US20050233405 Inhibitors of caspase-3-mediated cleavage of essential ventricular myosin light chain |
| 10/20/2005 | US20050233403 Human adipocyte cell populations and methods for identifying modulators of same |
| 10/20/2005 | US20050233400 Proteomic method for predicting success of rescue cerclage |
| 10/20/2005 | US20050233399 Rapid quantitative analysis of proteins or protein function in complex mixtures |
| 10/20/2005 | US20050233398 Lidocaine analogs and methods of making and using same |
| 10/20/2005 | US20050233397 Sensitively and specifically quantitate urokinase in all its forms; free from interferences from enzyme inhibitors that could affect fibrinolytic activity measurements; Diagnostic kits |
| 10/20/2005 | US20050233396 an assay method of infecting cultured cells with vaccinia virus;co-transfecting the cells with plasmids of DNA encoding the I7L protease enzyme such that both the substrate protein and enzyme are expressed; then measuring cleaved I7L protease |
| 10/20/2005 | US20050233395 Assays for detecting pathogenic respiratory bacteria |
| 10/20/2005 | US20050233394 Serological diagnostic method comprising positive control of introduction of human serum to be tested |
| 10/20/2005 | US20050233393 Dynamic hormone index as a biomarker for disease |
| 10/20/2005 | US20050233392 Diagnosis of hepatocellular carcinoma |
| 10/20/2005 | US20050233391 modulating expression of NKG2D in a lymphocyte capable of expressing NKG2D comprising binding a tumor cell produced MIC polypeptide with a monoclonal antibody; biomarker |
| 10/20/2005 | US20050233390 Device including a proteinaceous factor, a recombinant proteinaceous factor, and a nucleotide sequence encoding the proteinaceous factor |
| 10/20/2005 | US20050233389 Methods and compositions for peptide and protein labeling |
| 10/20/2005 | US20050233388 Method and apparatus for automated assessment of the immunoregulatory status of the mononuclear leukocyte immune system |
| 10/20/2005 | US20050233387 Assay method |
| 10/20/2005 | US20050233385 Using antibodies on cell surfaces |
| 10/20/2005 | US20050233384 Detection of antibodies to gangliosides using solid-phase reactants coated with carbonyl groups |
| 10/20/2005 | US20050233383 Human olfactory receptors and genes encoding same |
| 10/20/2005 | US20050233380 High throughput discovery of materials through vapor phase synthesis |
| 10/20/2005 | US20050233379 Methods of antagonizing morphogens |
| 10/20/2005 | US20050233378 Biosensor |
| 10/20/2005 | US20050233377 Drug screening method for the treatment of brain damage |
| 10/20/2005 | US20050233374 Reagents and methods useful for detecting diseases of the prostate |
| 10/20/2005 | US20050233371 CNG2B: a novel human cyclic nucleotide-gated ion channel |
| 10/20/2005 | US20050233368 Canine pancreatic lipase |
| 10/20/2005 | US20050233361 PPARdelta assay |
| 10/20/2005 | US20050233359 Isolated nucleic acid molecule encoding a neurotrophic growth factor |
| 10/20/2005 | US20050233357 Linking gene sequence to gene function by three dimensional (3D) protein structure determination |
| 10/20/2005 | US20050233356 Live-cell biosensor polypeptides and methods of use |
| 10/20/2005 | US20050233355 Human cDNAs encoding polypeptides having kinase functions |
| 10/20/2005 | US20050233353 Methods and compositions for categorizing patients |
| 10/20/2005 | US20050233352 Device and methods for processing samples and detecting analytes of low concentration |
| 10/20/2005 | US20050233351 Ultrasensitive immunoassays |
| 10/20/2005 | US20050233349 Crystal structure of ribosomal protein L11/GTPase activating region rRNA and uses thereof |
| 10/20/2005 | US20050233348 Using recombinant protein binding domains as tools for monitoring ligand binding activity in cells |
| 10/20/2005 | US20050233343 Composition of matter comprising library of analytes hybridized to nucleic acid array for generating complex formation and signaling domains |
| 10/20/2005 | US20050233339 Methods and compositions for determining the relationship between hybridization signal of aCGH probes and target genomic DNA copy number |
| 10/20/2005 | US20050233326 Drug screening for binding property or signal transduction between a G protein-coupled receptor and humanin or a salt; Alzheimer*s disease |
| 10/20/2005 | US20050233325 Integrated micro array system and methods therefor |
| 10/20/2005 | US20050233322 Method for producing a nucleosome preparation and use thereof in in vitro diagnosis of disseminated lupus erythematosus (dle) |
| 10/20/2005 | US20050233319 Methods and products for peptide-based cDNA characterization and analysis |
| 10/20/2005 | US20050233318 comprises identifier binding ligands; solid phase synthesis |
| 10/20/2005 | US20050233317 Modulate aptamer and method of detecting target protein by using the same |
| 10/20/2005 | US20050233313 Methods and reagents for identifying inhibitors of viral protease activity |
| 10/20/2005 | US20050233312 collecting a sample from an HIV-infected patient and extracting nucleic acid to determine if corresponding amino acid sequence comprises mutation selected from R41S, R41T, R41G and K70E in the protease region to determine a change in susceptibility of patient HIV strain to protease inhibitor |
| 10/20/2005 | US20050233310 Screening method |
| 10/20/2005 | US20050233309 Kinetic process for the detection, diagnosis, processing, and monitoring of clonal cell populations |
| 10/20/2005 | US20050233307 Site-specific labeling of affinity tags in fusion proteins |
| 10/20/2005 | US20050233306 Retentate chromatography and protein chip arrays with applications in biology and medicine |
| 10/20/2005 | US20050233304 Method of screening remedy for renal failure |
| 10/20/2005 | US20050233303 Reaction product of a polyvinyl benzyl halide with either (a) a bilinker or (b) a pi -electron donor to form a copolymer which copolymer is further reacted with a trisubstituted phosphine amine, a trisubstituted phosphine and mixtures |
| 10/20/2005 | US20050233037 Methods for casein determination in milk |
| 10/20/2005 | US20050232943 Antigenic composition of a Pseudomonas aeruginosa protein |
| 10/20/2005 | US20050232942 Virulence genes, proteins, and their use |
| 10/20/2005 | US20050232941 Compounds and methods for treatment and diagnosis of chlamydial infection |
| 10/20/2005 | US20050232937 Paramycobacterial diagnostics and vaccines |
| 10/20/2005 | US20050232929 detect, screen, and quantitate biological samples after administration of antibody conjugates, antibody-drug conjugates, antibodies, and fragments and metabolites thereof, by affinity separation, chromatography, and mass spectrometry; monomethyl auristatin drug and a thio-ether linkage |
| 10/20/2005 | US20050232927 Using notch gene expression as evaluative tool in detecting breast cancer |
| 10/20/2005 | US20050232922 Oncofetal antigen specific T-lymphocyte mediated immune response: manipulation and uses of oncofetal antigen specific CD4, CD8 cytotoxic and suppressor T cells and interleukin-10 |
| 10/20/2005 | US20050232916 Novel screens to identify agents that modulate retinal blood vessel function and pericyte function and diagnostic and therapeutic application therefor |
| 10/20/2005 | US20050232912 Enzyme phosphorylating ser46 of p53 |
| 10/20/2005 | US20050232862 Combination therapy for the treatment of estrogen-sensitive drugs |
| 10/20/2005 | US20050232860 Use of edg-receptor agonists for the treatment of hypertension |
| 10/20/2005 | US20050232824 High temperature electrolyte testing container |
| 10/20/2005 | US20050232822 High density plate filler |
| 10/20/2005 | US20050232821 High density plate filler |
| 10/20/2005 | US20050232820 For filling a microplate having wells each sized to receive an assay |
| 10/20/2005 | US20050232814 For testing urine glucose, urine protein, urine bilirubin, urine bilinogen, pancreatic amylase, urine hemoglobin, urine calcium, urine nitrite, urine ketone, and urine pH respectively; convenient and indicative measure, which is capable of showing a health condition of a user |
| 10/20/2005 | US20050232082 Measurement of air characteristics in the lower atmosphere |
| 10/20/2005 | US20050232046 Location-based real time data integration services |
| 10/20/2005 | US20050231716 Apparatus and method for measuring water quality using image data |
| 10/20/2005 | US20050231186 High throughput electrophysiology system |
| 10/20/2005 | US20050230713 Single-electron transistor for detecting biomolecules |
| 10/20/2005 | US20050230272 Porous biosensing device |
| 10/20/2005 | US20050230258 Apparatus and process for sensing fluoro species in semiconductor processing systems |
| 10/20/2005 | US20050230253 Capillary biosensor analysis system |
| 10/20/2005 | US20050230252 Microfluidic test device |
| 10/20/2005 | US20050229859 Controlled dilution system for drinking water and unit therefor |